Hospital de Jerez-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2022

  1. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

2020

  1. Update of the Andalusian Association of Urology protocol for the management of metastatic castration-resistant prostate cancer

    Actas Urologicas Espanolas

2018

  1. National recommendations document on the follow-up of patients with renal cell carcinoma

    Actas Urologicas Espanolas, Vol. 42, Núm. 6, pp. 381-388

  2. Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity

    Actas Urologicas Espanolas

2016

  1. Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer

    Tumor Biology, Vol. 37, Núm. 10, pp. 14301-14310

2014

  1. Experiencia inicial con acetato de abiraterona en pacientes con cáncer de próstata resistente a la castración

    Actas Urologicas Espanolas, Vol. 38, Núm. 5, pp. 339-345